TYSABRI (Natalizumab)-15ml

Tysabri (Natalizumab) is a synthetic protein that belongs to the class of medications called selective adhesion molecule inhibitors. It binds to immune cells in the blood stream, preventing them from passing from the blood into the central nervous system where they can damage nerves.

It us used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.

Enquiry Now
Category:

Additional information

Trade Name

TYSABRI

Generic Name

Natalizumab

Manufacturer

Biogen

Drug Type

Miscellaneous

Indication

Multiple Sclerosis

Doasage Form

Injectible

Packaging

1 x 15ml vial